We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+23.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$145M
AUM Growth
+$10.7M
Cap. Flow
-$39.5M
Cap. Flow %
-27.17%
Top 10 Hldgs %
27.16%
Holding
316
New
137
Increased
28
Reduced
59
Closed
75

Sector Composition

1 Healthcare 48.9%
2 Financials 13.82%
3 Technology 6.61%
4 Consumer Discretionary 5.8%
5 Materials 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
76
McKesson
MCK
$98.5B
$596K 0.41%
+772
New +$544K
APGE icon
77
Apogee Therapeutics
APGE
$10.1B
$589K 0.4%
14,819
+12,394
+511% +$473K
ABCB icon
78
Ameris Bancorp
ABCB
$6.21B
$566K 0.39%
+7,721
New +$543K
EDU icon
79
New Oriental
EDU
$7.82B
$565K 0.39%
+10,653
New +$526K
TERN
80
DELISTED
Terns Pharmaceuticals
TERN
$558K 0.38%
74,365
+14,568
+24% +$93K
ABR icon
81
Arbor Realty Trust
ABR
$996M
$555K 0.38%
+45,455
New +$529K
UWMC icon
82
UWM Holdings
UWMC
$685M
$554K 0.38%
+90,901
New +$477K
BKU icon
83
Bankunited
BKU
$3.55B
$520K 0.36%
+13,633
New +$516K
TBBK icon
84
The Bancorp
TBBK
$2.85B
$511K 0.35%
+6,819
New +$475K
TGTX icon
85
TG Therapeutics
TGTX
$8.4B
$507K 0.35%
14,041
-71,539
-84% -$2.36M
ARDX icon
86
Ardelyx
ARDX
$1.28B
$507K 0.35%
+92,046
New +$500K
RNAM
87
CALL
DELISTED
Avidity Biosciences
RNAM
$504K 0.35%
+458
New +$18.5K
ALKS icon
88
Alkermes
ALKS
$8.79B
$496K 0.34%
+16,541
New +$466K
CFG icon
89
Citizens Financial Group
CFG
$30.6B
$483K 0.33%
9,092
-4,990
-35% -$248K
BAC icon
90
Bank of America
BAC
$430B
$469K 0.32%
9,091
-9,687
-52% -$473K
EHTH icon
91
eHealth
EHTH
$47.3M
$466K 0.32%
108,106
ROIV icon
92
Roivant Sciences
ROIV
$24.8B
$419K 0.29%
+27,667
New +$343K
URGN icon
93
UroGen Pharma
URGN
$1.96B
$413K 0.28%
20,726
-13,874
-40% -$249K
AGNC icon
94
AGNC Investment
AGNC
$12.9B
$400K 0.28%
+40,908
New +$397K
FUTU icon
95
Futu Holdings
FUTU
$13.3B
$395K 0.27%
2,272
-7,728
-77% -$1.28M
NTLA icon
96
CALL
Intellia Therapeutics
NTLA
$1.59B
$354K 0.24%
+1,076
New +$13.3K
BE icon
97
Bloom Energy
BE
$61.1B
$354K 0.24%
+4,186
New +$194K
CRH icon
98
CRH
CRH
$68.8B
$351K 0.24%
2,926
-7,593
-72% -$802K
PCRX icon
99
Pacira BioSciences
PCRX
$1.01B
$350K 0.24%
13,575
SCPH
100
CALL
DELISTED
scPharmaceuticals
SCPH
$339K 0.23%
1,066
-57
-5% -$292

Similar funds

Persistent Asset Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Persistent Asset Partners held 316 positions worth $145M, up 7.9% from $135M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Persistent Asset Partners withdrew a net $39.5M in Q3 2025, closing 75 positions and reducing 59 holdings. Its most notable exit was Humana, an estimated $4.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 52% a quarter earlier, followed by Financials and Technology.

Against the trend, Persistent Asset Partners opened a new position in Centene worth $8.19M.

  • Persistent Asset Partners's largest Q3 2025 buy was Centene: 229,544 shares worth $8.19M.
  • Persistent Asset Partners added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $3.17M increase.
  • Persistent Asset Partners's biggest Q3 2025 reduction was iShares Bitcoin Trust, cutting an estimated $3.43M.
  • Persistent Asset Partners fully exited Humana in Q3 2025, selling an estimated $4.91M.
  • Persistent Asset Partners's ten largest holdings make up 27% of its $145M portfolio in Q3 2025.
  • Persistent Asset Partners opened 137 new positions and closed 75 in Q3 2025.
  • Persistent Asset Partners's portfolio value rose 7.9% quarter-over-quarter to $145M.

Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.